Why the study?
Patients with rheumatoid arthritis face twice the risk of ventricular arrhythmia and sudden cardiac death, prompting the hypothesis that beta-blocker treatment provides antiarrhythmic protection through synergistic anticatecholaminergic and anti-inflammatory effects.
Does propranolol reduce ventricular arrhythmia vulnerability and inflammation in a rat model of rheumatoid arthritis?
Population
Lewis rats with collagen-induced arthritis
Comparison
Propranolol 4 mg/kg vs untreated collagen-induced arthritis
Design
Preclinical animal study
Authors
Loading...
β-blockers merit testing for arrhythmia risk reduction in rheumatoid arthritis; leaves open translation from rat models to human outcomes.
Does propranolol reduce ventricular arrhythmia vulnerability and inflammation in a rat model of rheumatoid arthritis?
Propranolol demonstrates anti-inflammatory and antiarrhythmic effects in a rat model of rheumatoid arthritis, suggesting a potential mechanism for reducing sudden cardiac death risk in this population.
Lin et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: